Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]

K. Urakami, K. Takahashi, A. Okada, T. Oshima, Y. Adachi, S. Nakamura, N. Kitaguchi, Y. Tokushima, S. Yamamoto, S. Tanaka

Research output: Contribution to journalLetterpeer-review

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]'. Together they form a unique fingerprint.